Td Asset Management Inc Immunic, Inc. Transaction History

Td Asset Management Inc

  • $106 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021
SELL
$11.76 - $16.85 $383,705 - $549,781
-32,628 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$14.21 - $25.3 $110,838 - $197,340
7,800 Added 31.42%
32,628 $520,000
Q4 2020

Feb 16, 2021
BUY
$14.8 - $20.37 $367,454 - $505,746
24,828 New
24,828 $380,000

Others Institutions Holding IMUX

# of Institutions
75
Shares Held
51.2M
Call Options Held
824K
Put Options Held
354K
View Full List

About IMMUNIC, INC.

IMUX Quotes by TradingView
  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $35.1M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email